GSA CAPITAL PARTNERS LLP - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 86 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is 1.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q2 2023$32
-39.6%
34,307
-29.5%
0.00%
-40.0%
Q1 2023$53
-74.3%
48,637
-65.5%
0.01%
-80.8%
Q4 2022$206
-99.9%
141,084
-63.0%
0.03%
-51.9%
Q3 2022$410,000
+186.7%
381,043
+447.4%
0.05%
+184.2%
Q1 2022$143,000
-54.6%
69,612
-17.3%
0.02%
-52.5%
Q4 2021$315,000
-87.4%
84,129
-82.6%
0.04%
-84.3%
Q3 2021$2,506,000
+14.6%
484,782
-5.6%
0.26%
+3.7%
Q2 2021$2,187,000
+342.7%
513,388
+451.4%
0.25%
+200.0%
Q1 2021$494,000
-71.6%
93,112
-71.1%
0.08%
-71.2%
Q4 2020$1,740,000
+194.9%
322,744
+336.5%
0.28%
+190.8%
Q3 2020$590,000
+1034.6%
73,947
+284.8%
0.10%
+653.8%
Q1 2020$52,000
-57.7%
19,219
-81.3%
0.01%
-7.1%
Q4 2019$123,000
+17.1%
102,894
+47.6%
0.01%0.0%
Q3 2019$105,000
-54.7%
69,705
+20.9%
0.01%
-46.2%
Q2 2019$232,000
-21.9%
57,645
-16.6%
0.03%
-13.3%
Q1 2019$297,000
-65.1%
69,109
-9.0%
0.03%
-33.3%
Q1 2018$852,000
+252.1%
75,912
+40.9%
0.04%
+181.2%
Q2 2017$242,000
+191.6%
53,866
+356.4%
0.02%
+300.0%
Q3 2016$83,00011,8030.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q4 2021
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 1,377,294$1,501,2502.44%
NEA Management Company, LLC 17,079,779$18,616,9581.29%
Endurant Capital Management LP 1,660,835$1,810,3100.93%
Matrix Capital Management Company, LP 38,974,185$42,481,8620.58%
Long Focus Capital Management, LLC 5,435,439$5,924,6290.34%
PFM Health Sciences, LP 5,992,571$6,531,9020.29%
Key Client Fiduciary Advisors, LLC 321,155$350,0590.22%
DAFNA Capital Management LLC 351,064$382,6600.12%
Rock Springs Capital Management LP 2,787,845$3,038,7510.07%
Baker Brothers Advisors 9,830,877$10,715,6560.06%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders